Works about MYELODYSPLASTIC syndromes treatment

Results: 453
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group.

    Published in:
    2007
    By:
    • Galanopoulos, Athanasios G.;
    • Symeonidis, Argyris;
    • Kourakli, Aleka;
    • Papadaki, Eleni A.;
    • Tsaftaridis, Panagiotis;
    • Terpos, Evangelos;
    • Aktipi, Anthi;
    • Roussou, Paraskevi;
    • Protopappa, Maria;
    • Pappaioannou, Maria;
    • Zikos, Panagiotis;
    • Speletas, Mattheos;
    • Parcharidou, Agapi;
    • Laoutaris, Nikolaos;
    • Anagnostopoulos, Nikolaos I.;
    • Meletis, John;
    • Pangalis, Gerasimos A.;
    • Zoumbos, Nikolaos;
    • Viniou, Nora
    Publication type:
    Letter
    19
    20
    21
    22
    23
    24
    25

    New drugs.

    Published in:
    Australian Prescriber, 2010, v. 33, n. 3, p. 89
    Publication type:
    Article
    26
    27
    28

    Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.

    Published in:
    Cancer Medicine, 2017, v. 6, n. 12, p. 2814, doi. 10.1002/cam4.1231
    By:
    • Ali, Alaa M.;
    • Weisel, Daniel;
    • Gao, Feng;
    • Uy, Geoffrey L.;
    • Cashen, Amanda F.;
    • Jacoby, Meagan A.;
    • Wartman, Lukas D.;
    • Ghobadi, Armin;
    • Pusic, Iskra;
    • Romee, Rizwan;
    • Fehniger, Todd A.;
    • Stockerl‐Goldstein, Keith E.;
    • Vij, Ravi;
    • Oh, Stephen T.;
    • Abboud, Camille N.;
    • Schroeder, Mark A.;
    • Westervelt, Peter;
    • DiPersio, John F.;
    • Welch, John S.
    Publication type:
    Article
    29

    Clofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS.

    Published in:
    Cancer Medicine, 2016, v. 5, n. 11, p. 3068, doi. 10.1002/cam4.880
    By:
    • Chevallier, Patrice;
    • Labopin, Myriam;
    • La Tour, Regis Peffault;
    • Lioure, Bruno;
    • Bulabois, Claude ‐ Eric;
    • Huynh, Anne;
    • Blaise, Didier;
    • Turlure, Pascal;
    • Daguindau, Etienne;
    • Maillard, Natacha;
    • Yakoub ‐ Agha, Ibrahim;
    • Guillerm, Gaelle;
    • Delage, Jeremy;
    • Contentin, Nathalie;
    • Bay, Jacques ‐ Olivier;
    • Beckerich, Florence;
    • Bourhis, Jean ‐ Henri;
    • Detrait, Marie;
    • Vigouroux, Stéphane;
    • François, Sylvie
    Publication type:
    Article
    30
    31

    Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide.

    Published in:
    Cancer Medicine, 2016, v. 5, n. 7, p. 1694, doi. 10.1002/cam4.721
    By:
    • Rollison, Dana E.;
    • Shain, Kenneth H.;
    • Lee, Ji‐Hyun;
    • Hampras, Shalaka S.;
    • Fulp, William;
    • Fisher, Kate;
    • Al Ali, Najla H.;
    • Padron, Eric;
    • Lancet, Jeffrey;
    • Xu, Qiang;
    • Olesnyckyj, Martha;
    • Kenvin, Laurie;
    • Knight, Robert;
    • Dalton, William;
    • List, Alan;
    • Komrokji, Rami S.
    Publication type:
    Article
    32

    Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.

    Published in:
    Cancer Medicine, 2015, v. 4, n. 12, p. 1789, doi. 10.1002/cam4.523
    By:
    • Oliva, Esther N.;
    • Lauseker, Michael;
    • Aloe Spiriti, Maria Antonietta;
    • Poloni, Antonella;
    • Cortelezzi, Agostino;
    • Palumbo, Giuseppe A.;
    • Balleari, Enrico;
    • Sanpaolo, Grazia;
    • Volpe, Antonio;
    • Ricco, Alessandra;
    • Ronco, Francesca;
    • Alati, Caterina;
    • D'Errigo, Maria Grazia;
    • Santacaterina, Irene;
    • Kündgen, Andrea;
    • Germing, Ulrich;
    • Latagliata, Roberto
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course.

    Published in:
    Leukemia & Lymphoma, 2011, v. 52, n. 10, p. 2012, doi. 10.3109/10428194.2011.584990
    By:
    • Forghieri, Fabio;
    • Morselli, Monica;
    • Potenza, Leonardo;
    • Maccaferri, Monica;
    • Pedrazzi, Letizia;
    • Coluccio, Valeria;
    • Barozzi, Patrizia;
    • Vallerini, Daniela;
    • Riva, Giovanni;
    • Zanetti, Eleonora;
    • Quarelli, Chiara;
    • Bonacorsi, Goretta;
    • Artusi, Tullio;
    • Zaldini, Piera;
    • Zucchini, Patrizia;
    • Marasca, Roberto;
    • Narni, Franco;
    • Falini, Brunangelo;
    • Torelli, Giuseppe;
    • Luppi, Mario
    Publication type:
    Article
    45
    46
    47
    48
    49
    50